Loading…

F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: A prospective pilot study

Saved in:

Bibliographic Details
Published in:	Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2015-10, Vol.82 (5), p.381-383
Main Authors:	Edupuganti, Soujanya Ratna, Eder, Véronique, Ternant, David, Courtehoux, Maxime, Tranquart, François, Goupille, Philippe, Paintaud, Gilles, Mulleman, Denis
Format:	Article
Language:	English
Subjects:	Adalimumab Adalimumab - therapeutic use Adult Aged Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - diagnostic imaging Arthritis, Rheumatoid - drug therapy Female Fluorodeoxyglucose F18 Follow-Up Studies Humans Internal Medicine Male Middle Aged Pilot Projects Positron emission tomography Positron-Emission Tomography - methods Prospective Studies Radiopharmaceuticals Rheumatoid arthritis Rheumatology Time Factors Tumor necrosis factor antagonists Tumor Necrosis Factor-alpha - antagonists & inhibitors
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!